• Please log in or register to access this feature.

Commentary

You have free access to this content

Vitamin K and Bone: Past, Present, and Future†

  1. Caren M Gundberg*

Article first published online: 30 MAR 2009

DOI: 10.1359/jbmr.090312

Issue

Journal of Bone and Mineral Research

Journal of Bone and Mineral Research

Volume 24, Issue 6, pages 980–982, June 2009

Additional Information

How to Cite

Gundberg, C. M. (2009), Vitamin K and Bone: Past, Present, and Future. J Bone Miner Res, 24: 980–982. doi: 10.1359/jbmr.090312

Author Information

  1. Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, New Haven, Connecticut, USA

*Address correspondence to: Caren M. Gundberg, PhD, Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA

  1. †

    The author states that she has no conflicts of interest

Publication History

  1. Issue published online: 4 DEC 2009
  2. Article first published online: 30 MAR 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (431K)

REFERENCES

  • 1
    Binkley NC, Harke J, Krueger D, Engelke J, Vallarta-Ast N, Gemar D, Checovich M, Chappell R, Suttie J 2009 Vitamin K Treatment Reduces Undercarboxylated Osteocalcin But Does Not Alter Bone Turnover, Density or Geometry in Healthy Postmenopausal North American Women. J Bone Miner Res 24: 000–000.
    Direct Link:
  • 2
    Dam H 1935 The antihaemorrhagic vitamin of the chick. Biochemistry 29: 1273–1285.
  • 3
    Binkley SB, MacCorquodale DW, Thayer SA, Doisy EA 1939 The isolation of vitamin K1. J Biol Chem 130: 219–234.
  • 4
    Campbell HA, Roberts WL, Smith WK, Link KP 1940 Studies on the hemorrhagic sweet clover disease. I. The preparation of hemorrhafic concentrates. J Biol Chem 136: 47–55.
  • 5
    Stenflo J, Fernlund P, Egan W, Roepstorff P 1974 Vitamin K-dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci USA 71: 2730–2733.
  • 6
    Nelsestuen GL, Zytkovicz TH, Howard JB 1974 The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin. J Biol Chem 249: 6347–6350.
  • 7
    Suttie JW 1993 Synthesis of vitamin K-dependent proteins. FASEB J 7: 445–452.
  • 8
    Pettifor JM, Benson R 1975 Congenital malformations associated with the administration of oral anticoagulants during pregnancy. J Pediatr 86: 459–462.
  • 9
    Hauschka PV, Lian JB, Gallop PM 1975 Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci USA 72: 3925–3929.
  • 10
    Price PA, Urist MR, Otawara Y 1983 Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun 117: 765–771.
  • 11
    Viegas CSB, Simes DC, Laize V, Williamson MK, Price PA, Cancela ML 2008 Gla-rich protein (GRP), a new vitamin K–dependent protein identified from sturgeon cartilage and highly conserved in vertebrates. J Biol Chem 283: 36655–36664.
  • 12
    Shearer MJ, Newman P 2008 Metabolism and cell biology of vitamin K. Thromb Haemost 100: 530–547.
  • 13
    Suttie JW 1995 The importance of menaquinones in human nutrition. Annu Rev Nutr 15: 399–417.
  • 14
    Sokoll LJ, Sadowski JA 1996 Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am J Clin Nutr 63: 566–573.
  • 15
    Sokoll LJ, Booth SL, O'Brien ME, Davidson KW, Tsaioun KI, Sadowski JA 1997 Changes in serum osteocalcin, plasma phylloquinone, and urinary gamma- carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am J Clin Nutr 65: 779–784.
  • 16
    Szulc P, Chapuy MC, Meunier PJ, Delmas PD 1993 Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91: 1769–1774.
  • 17
    Szulc P, Chapuy MC, Meunier PJ, Delmas PD 1996 Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: A three year follow-up study. Bone 18: 487–488.
  • 18
    Caraballo PJ, Gabriel SE, Castro MR, Atkinson EJ, Melton LJ 1999 Changes in bone density after exposure to oral anticoagulants: A meta-analysis. Osteoporos Int 9: 441–448.
  • 19
    Pearson DA 2007 Bone health and osteoporosis: The role of vitamin K and potential antagonism by anticoagulants. Nutr Clin Pract 22: 517–544.
  • 20
    Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA 1999 Vitamin K intake and hip fractures in women: A prospective study. Am J Clin Nutr 69: 74–79.
  • 21
    Booth S, Broe K, Gagnon D, Tucker KL, Hannan MT, McLean RR, Dawson-Hughes B, Wilson PW, Cupples LA, Kiel DP 2003 Vitamin K intake and bone mineral density in women and men. Am J Clin Nutr 77: 512–516.
  • 22
    Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PWF, Kiel DP 1999 Potassium, magnesium and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr 69: 727–736.
  • 23
    Ikeda Y, Iki M, Morita A, Kajita E, Kagamimori S, Kagawa Y, Yoneshimay H 2006 Intake of fermented soybeans, natto, Is associated with reduced bone loss in postmenopausal women: Japanese population-based Osteoporosis (JPOS) Study. J Nutr 136: 1323–1328.
  • 24
    Nanke Y, Kotake S, Ninomiya T 2005 Geranylgeranylacetone inhibits formation and function of human osteoclasts and prevents bone loss in tail-suspended rats and ovariectomized rats. Calcif Tissue Int 77: 376–385.
  • 25
    Cockayne S, Adamson J, Lanhamp-New S, Shearer MJ, Gilbody S, Torgerson DJ 2006 vitamin K and the prevention of fractures: Systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 166: 1256–1261.
  • 26
    Booth SL, Dallal G, Shea MK, Gundberg C, Peterson JW, Dawson-Hughes B 2008 Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab 93: 1217–1223.
  • 27
    Tamura T, Morgan SL, Takimoto H 2007 Vitamin K and the prevention of fractures. Arch Intern Med. 167: 94.
  • 28
    Halbekath JM, Schenk S, von Maxen A, Meyer G, Mühlhauser I 2007 Prevention of hip fractures: Concern about validity of trials. Arch Intern Med. 167: 513–514.
  • 29
    Bolton-Smith C, McMurdo ME, Paterson CR, Mole PA, Harvey JM, Fenton ST, Prynne CJ, Mishra GD, Shearer MJ 2007 Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women. J Bone Miner Res 22: 509–519.
    Direct Link:
  • 30
    Cheung AM, Tile L, Lee Y, Tomlinson G, Hawker G, Scher J, Hu H, Vieth R, Thompson L, Jamal S, Josse R 2008 Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): A randomized controlled trial. PLoS Med 5: e196.
  • 31
    Binkley NC, Krueger DC, Foley AL, Engelke JA, Suttie JW 2000 Vitamin K supplementation reduces serum under gamma-carboxylated osteocalcin concentration in healthy adults. Am J Clin Nutr 72: 1523–1528.
  • 32
    Knapen MHJ, Schurgers LJ, Vermeer C 2007 Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int 18: 963–972.
  • 33
    Eisai 2005 Eisai announces the intermediate analysis of anti-osteoporosis treatment post-marketing research to investigate the benefits of menatetreone as part of the Ministry of Health, Labor, and Welfare's pharmacoepidemiological drug review program. Available at www.eisai.co.jp/enews/enews200506.html. Accessed October 5, 2007.
  • 34
    Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang A, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G 2007 Endocrine regulation of energy metabolism by the skeleton. Cell 130: 456–469.
  • 35
    Yoshida M, Jacques PF, Meigs JB, Saltzman E, Shea MK, Gundberg C, Dawson-Hughes B, Dallal G, Booth SL 2008 Effect of vitamin K supplementation on insulin resistance in older men and women. Diabetes Care 31: 2092–2096.
View Full Article (HTML) Get PDF (431K)